StonvexLoading…
StonvexCore line items from BLLN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q1 2025 2025-03-31 |
|---|---|---|---|---|
Revenue | $108.39M | $305.11M | $209.06M | $58.96M |
Operating Income | $17.83M | $16.02M | $5.69M | $-2.31M |
Net Income | $17.97M | $7.45M | $1.48M | $-3.99M |
EPS (Diluted) | $0.34 | $0.14 | $0.03 | $-0.39 |
Total Assets | $700.73M | $632.65M | $327.52M | Not available |
Total Liabilities | $195.11M | $152.55M | $147.63M | Not available |
Cash & Equivalents | $537.45M | $495.98M | $195.15M | $191.60M |
Free Cash Flow OCF − CapEx | $10.96M | $15.71M | $6.46M | $278.00K |
Shares Outstanding | 53.03M | 21.23M | 11.18M | 10.31M |